Suchergebnisse - "Geretti, Anna Maria"

PubPharm (316)

41

Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Mallalieu, N. | Winter, E. | Fettner, S. | +8

42

Hepatitis D prevalence : problems with extrapolation to global population estimates

enthalten in: Gut | 2020

von Stockdale, A. | Kreuels, B. | Henrion, M. | +3

CommentOn: Gut. 2018 Sep 18;:null. - PMID 30228220

43

Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa

enthalten in: EClinicalMedicine | 2020

von Villa, G. | Abdullahi, A. | Owusu, D. | +9

44

Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Tzou, P. | Rhee, S. | Descamps, D. | +13

45

Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection : Public Health England HCV Resistance Group

enthalten in: The Journal of infection | 2019

von Bradshaw, D. | Mbisa, J. | Geretti, A. | +12

46

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV

enthalten in: Journal of virus eradication | 2019

von Stirrup, O. | Sabin, C. | Phillips, A. | +106

47

An apparent paradox : resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapy

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Geretti, A. | Abdullahi, A. | Mafotsing Fopoussi, O. | +6

48

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Mbisa, J. | Kirwan, P. | Tostevin, A. | +75

49

Evolution of the burden of active hepatitis C virus infection in England from September 2015 to September 2016 : a repeated cross-sectional analysis

enthalten in: BMJ open | 2019

von Lacoin, L. | Hurst, M. | Hill, N. | +7

50

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER) : final results of a multicentre, prospective, observational study

enthalten in: Lancet (London, England) | 2019

von Rodger, A. | Cambiano, V. | Bruun, T. | +134

CommentIn: Lancet HIV. 2019 Apr;6(4):e211-e213. - PMID 30772420